Juli Miller | Head-Investor Relations |
Adrian Rawcliffe | Chief Executive Officer |
Dennis Williams | Senior Vice President, Late Stage Development |
Helen Tayton-Martin | Chief Business & Strategy Officer |
Joanna Brewer | Chief Scientific Officer |
John Lunger | Chief Patient Supply Officer |
Marc Frahm | TD Cowen |
Tony Butler | EF Hutton |
Hello. Welcome to Adaptimmune's First Quarter Call and Business Update. I would now like to turn the call over to Juli Miller. Juli, please go ahead.
Good morning, and welcome to Adaptimmune's conference call to discuss our first quarter 2023 financial results and business updates.